Calcium regulation by calcium antagonists /

Saved in:
Bibliographic Details
Imprint:Washington, DC : American Chemical Society, 1982.
Description:1 online resource (228 pages) : illustrations.
Language:English
Series:ACS symposium series, 1947-5918 ; 201
ACS symposium series ; 201.
Subject:
Format: E-Resource Book
Local Note:American Chemical Society, ACS Symposium Series eBooks - 1982 Front Files.
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/12564648
Hidden Bibliographic Details
Other authors / contributors:Rahwan, Ralf G., 1941- editor.
Witiak, Donald T., editor.
American Chemical Society. Division of Medicinal Chemistry, sponsoring body.
aAmerican Chemical Society. Meeting (182nd : 1981 : New York, N.Y.)
ISBN:9780841209688
Notes:"Based on a symposium sponsored by the ACS Division of Medicinal Chemistry at the 182nd Meeting of the American Chemical Society, New York, New York, August 23-28, 1981."
Distributed in print by Oxford University Press.
Includes bibliographical references and index.
Description based on publisher-supplied information and home-page.
Other form:Original 9780841207448 (alk. paper)
Original 0841207445 (alk. paper)
Online version
Standard no.:bk-1982-0201

MARC

LEADER 00000nam a2200000 i 4500
001 12564648
006 m fo d
007 cr cn nnnauuuu
008 180405s1982 dcua ob 101 0 eng d
003 ICU
020 |a 9780841209688  |q electronic 
024 8 |a bk-1982-0201 
035 |a (ACS)ccn00831260 
040 |a NjRocCCS  |b eng  |e rda  |c NjRocCCS 
050 4 |a QP535.C2  |b C265 1982 
060 4 |a QV 276  |b C1443 1982 
082 0 4 |a 612/.01524  |2 19 
084 |a MED075000  |a SCI036000  |2 bisacsh 
245 0 0 |a Calcium regulation by calcium antagonists /  |c Ralf G. Rahwan, editor, Donald T. Witiak, editor. 
264 1 |a Washington, DC :  |b American Chemical Society,  |c 1982. 
300 |a 1 online resource (228 pages) :  |b illustrations. 
336 |a text  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a computer  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/c 
338 |a online resource  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/cr 
490 1 |a ACS symposium series,  |x 1947-5918 ;  |v 201 
500 |a "Based on a symposium sponsored by the ACS Division of Medicinal Chemistry at the 182nd Meeting of the American Chemical Society, New York, New York, August 23-28, 1981." 
500 |a Distributed in print by Oxford University Press. 
504 |a Includes bibliographical references and index. 
505 0 0 |t Calcium Antagonists: Classification and Properties /  |r NAYLER, WINIFRED G. /  |u http://dx.doi.org/10.1021/bk-1982-0201.ch001 --  |t Chemical Pharmacology of Calcium Antagonists /  |r TRIGGLE, D. J. /  |u http://dx.doi.org/10.1021/bk-1982-0201.ch002 --  |t Effects of Calcium Inhibitory Compounds upon the Cardiovascular System /  |r MUIR, WILLIAM W. /  |u http://dx.doi.org/10.1021/bk-1982-0201.ch003 --  |t Control of Intracellular Calcium in Smooth Muscle /  |r DANIEL, E. E.; GROVER, A. K.; KWAN, C. Y. /  |u http://dx.doi.org/10.1021/bk-1982-0201.ch004 --  |t Calmodulin: An Intracellular Ca2+ Receptor Protein /  |r BROSTROM, CHARLES O.; BROSTROM, MARGARET A.; WOLFF, DONALD J. /  |u http://dx.doi.org/10.1021/bk-1982-0201.ch005 --  |t Pharmacology of Intracellular Calcium Antagonistic Methylenedioxyindenes /  |r RAHWAN, RALF G.; WITIAK, DONALD T. /  |u http://dx.doi.org/10.1021/bk-1982-0201.ch006 --  |t Pharmacologic Consequences of Calcium Interactions with Opioid Alkaloids and Peptides /  |r CHAPMAN, DAVID, Current address: University of Oxford, Department of Human Anatomy, Oxford 0X1 3QK, England; WAY, E. LEONG /  |u http://dx.doi.org/10.1021/bk-1982-0201.ch007 --  |t Calcium Antagonism and Antiepileptic Drugs /  |r FERRENDELLI, JAMES A. /  |u http://dx.doi.org/10.1021/bk-1982-0201.ch008 --  |t Relationship of Cyclic Nucleotides and Calcium in Platelet Function /  |r LE BRETON, G. C.; OWEN, N. E.; FEINBERG, H. /  |u http://dx.doi.org/10.1021/bk-1982-0201.ch009 --  |t Suppression of Atherogenesis with a Membrane-Active Agent-Nifedipine /  |r HENRY, PHILIP D.; BENTLEY, KAREN /  |u http://dx.doi.org/10.1021/bk-1982-0201.ch010 --  |t Calcium and the Secretory Process /  |r BOROWITZ, J. L.; SEYLER, DAVID E., Current address: Medical College of Virginia, Department of Pharmacology, Richmond, Va. 23298; KUTA, CELESTE C. /  |u http://dx.doi.org/10.1021/bk-1982-0201.ch011 
588 |a Description based on publisher-supplied information and home-page. 
590 |a American Chemical Society, ACS Symposium Series eBooks - 1982 Front Files. 
650 0 |a Calcium  |x Physiological effect.  |0 http://id.loc.gov/authorities/subjects/sh85018774 
650 0 |a Calcium  |x Antagonists.  |0 http://id.loc.gov/authorities/subjects/sh85018769 
650 0 |a Pharmacology.  |0 http://id.loc.gov/authorities/subjects/sh85100599 
650 0 |a Cardiovascular pharmacology.  |0 http://id.loc.gov/authorities/subjects/sh90001899 
650 0 |a Intracellular calcium  |x Biological control. 
650 0 |a Calmodulin.  |0 http://id.loc.gov/authorities/subjects/sh85019015 
650 0 |a Intracellular calcium  |x Antagonists. 
650 0 |a Calcium  |x Reactivity. 
650 0 |a Anticonvulsants.  |0 http://id.loc.gov/authorities/subjects/sh85005657 
650 0 |a Cyclic nucleotides.  |0 http://id.loc.gov/authorities/subjects/sh85035068 
650 0 |a Blood platelets  |x Mechanism of action. 
650 0 |a Nifedipine  |x Reactivity. 
650 0 |a Calcium  |x Secretion. 
650 1 2 |a Calcium  |x antagonists & inhibitors. 
650 1 2 |a Calcium  |x metabolism. 
650 1 2 |a Calcium Channel Blockers  |x metabolism. 
650 1 2 |a Ion Channels  |x metabolism. 
650 1 2 |a Calcium. 
650 1 2 |a Pharmacological and Toxicological Phenomena. 
650 1 2 |a Cardiovascular Agents  |x pharmacology. 
650 1 2 |a Cardiovascular Diseases  |x drug therapy. 
650 1 2 |a Calmodulin. 
650 1 2 |a Anticonvulsants. 
650 1 2 |a Nucleotides, Cyclic. 
650 1 2 |a Blood Platelets. 
650 1 2 |a Nifedipine  |x metabolism. 
650 7 |a MEDICAL / Physiology.  |2 bisacsh 
650 7 |a SCIENCE / Life Sciences / Human Anatomy & Physiology.  |2 bisacsh 
700 1 |a Rahwan, Ralf G.,  |d 1941-  |e editor.  |0 http://id.loc.gov/authorities/names/n82117386  |1 http://viaf.org/viaf/112515793 
700 1 |a Witiak, Donald T.,  |e editor.  |0 http://id.loc.gov/authorities/names/n82116900  |1 http://viaf.org/viaf/70280880 
710 2 |a American Chemical Society.  |b Division of Medicinal Chemistry,  |e sponsoring body.  |0 http://id.loc.gov/authorities/names/n79099045  |1 http://viaf.org/viaf/140564602 
710 2 |a aAmerican Chemical Society.  |b Meeting  |n (182nd :  |d 1981 :  |c New York, N.Y.) 
776 1 |c Original  |z 9780841207448 (alk. paper) 
776 1 |c Original  |z 0841207445 (alk. paper) 
776 1 |c Online version  |w (OCoLC)990459271 
830 0 |a ACS symposium series ;  |v 201.  |x 1947-5918 
856 4 0 |u https://pubs.acs.org/doi/book/10.1021/bk-1982-0201  |y ACS 
903 |a HeVa 
929 |a eresource 
999 f f |i 30985559-df65-5e2c-b014-f271fb037643  |s 1f574a7f-d882-54ab-a9e9-30a570674f7e 
928 |t Library of Congress classification  |a QP535.C2 C265 1982  |l Online  |c UC-FullText  |u https://pubs.acs.org/doi/book/10.1021/bk-1982-0201  |z ACS  |g ebooks  |i 12485180